WHITNEY STEVENS: Open Payments
NPI 1366021149 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,023 in 68 payments from 34 companies in 2025. Trend: 2023 $2,967 · 2024 $2,111 · 2025 $2,023
Food & beverage: $1,751Education: $272
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $203 |
| Geron Corporation | 4 | $174 |
| Janssen Biotech, Inc. | 8 | $171 |
| Stemline Therapeutics Inc. | 5 | $162 |
| Astellas Pharma Global Development | 1 | $125 |
| Eisai Inc. | 2 | $119 |
| Merck Sharp & Dohme LLC | 5 | $109 |
| SANOFI-AVENTIS U.S. LLC | 1 | $93 |
| Adaptive Biotechnologies Corporation | 1 | $72 |
| Janssen Scientific Affairs, LLC | 1 | $72 |
Products named: RYTELO, Orserdu, Xtandi, Lenvima, RYBREVANT, SARCLISA, KEYTRUDA, IMBRUVICA.
Industry payments across LA — which companies pay providers there.
